Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS.
Previous studies in children with chronic kidney disease (CKD) have identified low hemoglobin as a risk factor for poor outcomes. A retrospective review of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) CKD registry was performed to identify the prevalence of and risk factors for anemia among children with stage 3 CKD, including both patients with low hemoglobin and those whose hemoglobin normalized with an erythropoiesis-stimulating agent (ESA). At enrollment, 2,792 patients had stage 3 CKD. Mean age was 9.5 (+/-0.11) years, 62.1% were male, 61.3% were white, and 43.7% had structural/urologic disease. Among 1,640 of those patients with 12 month follow-up data available for multivariate analysis, 73% met the criteria for anemia. Multivariate logistic regression analysis identifying risk factors for anemia at the 12-month follow-up revealed that, after controlling for estimated glomerular filtration rate, age >2 years, male sex, earlier era of study entry, and prescription of anti-hypertensive medications are associated with an increased risk for anemia at 12 months. In addition, multivariate Cox proportional hazards regression analysis revealed that when patients with ESA-corrected hemoglobin are included in the definition, anemia is not associated with increased risk of progression to end stage renal disease (dialysis initiation or transplantation).
Atkinson
Meredith A
MA
Division of Pediatric Nephrology, Johns Hopkins University, 200 N Wolfe St, Baltimore, MD 21287, USA. matkins3@jhmi.edu
Martz
Karen
K
Warady
Bradley A
BA
Neu
Alicia M
AM
D000293:Adolescent; D000740:Anemia / Q000097:blood / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D016009:Chi-Square Distribution; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005260:Female; D006397:Hematinics / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007674:Kidney Diseases / Q000097:blood / Q000150:complications* / Q000453:epidemiology / Q000628:therapy; D016015:Logistic Models; D008297:Male; D009656:North America / Q000453:epidemiology; D016017:Odds Ratio; D015995:Prevalence; D016016:Proportional Hazards Models; D012042:Registries; D017582:Renal Replacement Therapy; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index
D006397:Hematinics
Transpl Int. 2008 Apr;21(4):304-13
18266774
J Am Soc Nephrol. 2006 Oct;17(10):2878-85
16943308
Pediatr Nephrol. 2007 May;22(5):702-7
17216248
Curr Opin Nephrol Hypertens. 2008 May;17(3):292-7
18408481
Contrib Nephrol. 2008;161:247-254
18451684
Semin Nephrol. 2006 Jul;26(4):261-8
16949463
Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
11904577
N Engl J Med. 1993 Jan 21;328(3):171-5
8417383
Am J Kidney Dis. 2007 Sep;50(3):471-530
17720528
Pediatr Nephrol. 2008 Feb;23(2):209-19
17245602
Pediatr Nephrol. 2009 Mar;24(3):435-7
18696118
Pediatr Nephrol. 2009 Mar;24(3):571-9
18800231
Pediatr Nephrol. 2007 Feb;22(2):265-71
17120062
Am J Kidney Dis. 2004 Dec;44(6):1017-23
15558522
J Pediatr. 2006 Nov;149(5):671-5
17095341
Clin J Am Soc Nephrol. 2008 Mar;3(2):457-62
18235140
Am J Kidney Dis. 2006 May;47(5 Suppl 3):S11-145
16678659
Pediatr Clin North Am. 1987 Jun;34(3):571-90
3588043
Curr Med Res Opin. 2004 Sep;20(9):1501-10
15383200
Pediatr Nephrol. 2008 May;23(5):705-16
18335252
Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S46-55
18359408
Clin J Am Soc Nephrol. 2009 Jan;4(1):48-56
19056614